Drug Farm, a pharmaceutical company, has successfully closed the first tranche of its Series D funding round, securing $55 million. The investment was co-led by Shanghai Pudong Lingqu Investment Center and Shanghai Puxing Synergistic Private Equity Fund Partnership. Existing investors also participated in this round. The company plans to utilize these funds to advance its clinical and preclinical research pipelines, accelerate global development projects, bolster regulatory efforts in key markets, and expand its research capabilities. AI
IMPACT N/A
RANK_REASON Significant funding round for a pharmaceutical company. [lever_c_demoted from significant: ic=1 ai=0.0]
- Drug Farm
- Shanghai Pudong Lingqu Investment Center
- Shanghai Puxing Synergistic Private Equity Fund Partnership
- YD Capital
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
